Solmaz Roshandel1, Minoor Lamyian2, Seyed Ali Azin3, Shahpar Haghighat4, Eesa Mohammadi5. 1. Department of Reproductive Health and Midwifery, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran. 2. Department of Reproductive Health and Midwifery, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran. lamyianm@modares.ac.ir. 3. Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran. 4. Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran. 5. Department of Nursing, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
Abstract
BACKGROUND: Sexual and reproductive health problems significantly decrease quality of life in survivors of breast cancer. The best approach is to provide services according to evidence-based guidelines developed based on their practical context. Here, we aim to develop and validate a guideline on the sexual and reproductive health of breast cancer survivors in Iran. METHODS: The guideline will be developed and validated using an exploratory sequential mixed methods approach in three phases: (1) describing sexual and reproductive health needs of survivors of breast cancer in Iran and the health services they receive in this regard, (2) performing a systematic review of existing guidelines, resources, and documents on the sexual and reproductive health of breast cancer survivors worldwide, and (3) developing and validating a guideline on the sexual and reproductive health of women who survived breast cancer in Iran based on the results of phases 1 and 2 through multiple steps. DISCUSSION: A comprehensive and practical guideline on the sexual and reproductive health of breast cancer survivors in Iran will be developed which will be compatible with their specific needs and culture, considering the limited resources available. This guideline can significantly improve the quality of life in breast cancer survivors in Iran. In addition, the approach we will use here can be utilized to develop guidelines on sexual and reproductive health of female cancer survivors in general.
BACKGROUND: Sexual and reproductive health problems significantly decrease quality of life in survivors of breast cancer. The best approach is to provide services according to evidence-based guidelines developed based on their practical context. Here, we aim to develop and validate a guideline on the sexual and reproductive health of breast cancer survivors in Iran. METHODS: The guideline will be developed and validated using an exploratory sequential mixed methods approach in three phases: (1) describing sexual and reproductive health needs of survivors of breast cancer in Iran and the health services they receive in this regard, (2) performing a systematic review of existing guidelines, resources, and documents on the sexual and reproductive health of breast cancer survivors worldwide, and (3) developing and validating a guideline on the sexual and reproductive health of women who survived breast cancer in Iran based on the results of phases 1 and 2 through multiple steps. DISCUSSION: A comprehensive and practical guideline on the sexual and reproductive health of breast cancer survivors in Iran will be developed which will be compatible with their specific needs and culture, considering the limited resources available. This guideline can significantly improve the quality of life in breast cancer survivors in Iran. In addition, the approach we will use here can be utilized to develop guidelines on sexual and reproductive health of female cancer survivors in general.
Entities:
Keywords:
Breast cancer; Clinical practice guideline; Mixed methods study; Sexual and reproductive health; Study protocol
Authors: Joanna Streb; Marcin Jacek Jabłoński; Agnieszka Słowik; Dorota Babczyk; Robert Jach Journal: Ann Agric Environ Med Date: 2018-05-11 Impact factor: 1.447
Authors: Jeanne Carter; Christina Lacchetti; Barbara L Andersen; Debra L Barton; Sage Bolte; Shari Damast; Michael A Diefenbach; Katherine DuHamel; Judith Florendo; Patricia A Ganz; Shari Goldfarb; Sigrun Hallmeyer; David M Kushner; Julia H Rowland Journal: J Clin Oncol Date: 2017-12-11 Impact factor: 44.544
Authors: Sharon L Bober; Jennifer B Reese; Lisa Barbera; Andrea Bradford; Kristen M Carpenter; Shari Goldfarb; Jeanne Carter Journal: Curr Opin Support Palliat Care Date: 2016-03 Impact factor: 2.302
Authors: Mohammad Esmaeil Akbari; Soheila Sayad; Saed Sayad; Maryam Khayamzadeh; Leila Shojaee; Zeynab Shormeji; Mojtaba Amiri Journal: Int J Breast Cancer Date: 2017-11-01
Authors: Lisa Ljungman; Johan Ahlgren; Lena-Marie Petersson; Kathryn E Flynn; Kevin Weinfurt; Jessica R Gorman; Lena Wettergren; Claudia Lampic Journal: Psychooncology Date: 2018-09-27 Impact factor: 3.894
Authors: J Ferlay; M Colombet; I Soerjomataram; C Mathers; D M Parkin; M Piñeros; A Znaor; F Bray Journal: Int J Cancer Date: 2018-12-06 Impact factor: 7.396